Skip to main content

Table 4 Significant correlations between gene expression and clinical data

From: Differential gene expression of ABCG2, SLC22A12, IL-1β, and ALPK1 in peripheral blood leukocytes of primary gout patients with hyperuricemia and their comorbidities: a case–control study

 

Patients

Total population

Correlation coeficient

Significant level (2 tailed)

n

Correlation coeficient

Significant level (2 tailed)

n

ABCG2

 

 Creatinin (PBMCs)

0.915 #

p < 0.001

18

0.875 #

p < 0.001

34

 Uric Acid (PMNLs)

NS

NS

18

0.421 §

p < 0.05

35

SLC22A12

 MS (PBMCs)

0.473 §

p < 0.05

20

NS

NS

34

 UA (PBMCs)

0.449 §

p < 0.05

21

NS

NS

35

 TAG (PBMCs)

0.466 #

p < 0.05

21

NS

NS

34

 TAG (PMNLs)

0.550§

p < 0.05

15

NS

NS

34

 RD (PMNLs)

0.525 #

p < 0.05

16

0.663 §

p < 0.001

15

 Hypertension (PMNLs)

0.511 #

p < 0.05

16

NS

NS

36

ALPK1

 Creatinin (PBMCs)

0.654 §

p < 0.001

16

NS

NS

34

 BMI (PBMCs)

NS

NS

18

0.443 §

p < 0.001

39

 Uric Acid (PBMCs)

0.574 §

p < 0.05

16

NS

NS

37

 CRP (PMNLs)

0.620 §

p < 0.05

12

NS

NS

30

 IL-1β

 Hypertension (PMNLs)

0.579 §

p < 0.05

15

NS

NS

35

  1. §Correlation coeficient Spearman, #Correlation coeficient Pearson. NS non significant